A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU

NCT03020992 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis (axSpA)
Anterior Uveitis (AU)

Interventions

DRUG: Certolizumab Pegol

Sponsor

UCB Biopharma SRL